ILLUMINA, INC.
For the period ended Mar 29, 2026. Filed May 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 29, 2026 · Filed May 4, 2026
ILMN$220.78+3.6%Stored close · as of Nov 9, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2025-09-28; filed 2025-10-31.
0001110803-25-000073
Item 1A. Risk FactorsShare Repurchases and SalesAdoptions, Modifications or Terminations of Trading PlansCurrent report: 10-Q
Period ended 2026-03-29; filed 2026-05-04.
0001110803-26-000092
Item 1A. Risk FactorsShare Repurchases and SalesAdoptions, Modifications or Terminations of Trading PlansThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 10 previous paragraphs and 17 current paragraphs.
7 unchanged; 3 reworded; 7 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (7)
Current report
Armed conflict, geopolitical instability, or sanctions could adversely affect our business and results of operations.
Current report
Armed conflict and geopolitical instability, such as in Ukraine, Russia, Iran, and other parts of the Middle East could adversely affect global economic conditions and negatively impact our business, results of operations, cash flows, financial condition, or growth prospects. The scope, duration, and broader consequences of such conflicts are inherently uncertain and may escalate or evolve in ways that are difficult to predict.
Current report
Ongoing or future armed conflicts and geopolitical tensions have led, and may continue to lead, to the imposition of sanctions, export controls, trade restrictions, and other restrictive measures by the United States and other governments, as well as countermeasures in response. These measures, together with related compliance obligations, have affected, and may continue to affect, our ability to sell products, provide services, conduct financial transactions, or ship products into certain regions, including limitations on our ability to collect or pay amounts owed by or to certain counterparties.
Current report
For example, ongoing armed conflict between Russia and Ukraine has made business activities in certain affected regions challenging and, in some cases, impracticable. In addition, armed conflict and instability in Iran and elsewhere in the Middle East has caused, and may continue to cause, volatility in global energy markets, including higher fuel and energy costs, and could disrupt global transportation routes, logistics networks, or supply chains, which could increase our operating costs, delay deliveries, constrain manufacturing or sourcing activities, or otherwise adversely affect our business.
Current report
During the quarterly period ended March 29, 2026, the following directors or officers adopted, modified, or terminated 10b5-1 plans:
Current report
•On February 26, 2026, Scott Ericksen, our Chief Accounting Officer, entered into a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on February 26, 2027 and provides for the sale of up to 2,271 shares.
Current report
•On March 3, 2026, Patricia Leckman, our Chief People Officer, entered into a new arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The arrangement terminates on March 3, 2027 and provides for the sale of up to 1,567 shares.
Reworded paragraphs (3)
Previous wording
Our business is subject to various risks, including those described in “Risk Factors” within the Business & Market Information section of our Annual Report on Form 10-K for the fiscal year ended December 29, 2024, and the “Other Key Information” section of our Quarterly Report on Form 10-Q for the periods ended March 30, 2025 and June 29, 2025, which we strongly encourage you to review.
Current wording
Our business is subject to various risks, including those described in “Risk Factors” within the Business & Market Information section of our Annual Report on Form 10-K for the fiscal year ended December 28, 2025. In addition to the risk factors disclosed in our Form 10-K, the issues raised in the following risk factor could adversely affect our operating results and stock price:
Previous wording
In August 2024, our Board of Directors authorized a new share repurchase program, which cancels and supersedes all prior and available repurchase authorizations, to repurchase up to $1.5 billion of our outstanding common stock. The repurchases may be completed through open market purchases, pursuant to Rule 10b5-1 or Rule 10b-18, or through an accelerated share repurchase program. Shares repurchased in open market transactions pursuant to this program during Q3 2025 were as follows:
Current wording
In August 2024, our Board of Directors authorized the 2024 Repurchase Program, which canceled and superseded all prior and available repurchase authorizations, to repurchase up to $1.5 billion of our outstanding common stock. The repurchases may be completed through open market purchases, pursuant to Rule 10b5-1 or Rule 10b-18, or through an accelerated share repurchase program. Shares repurchased in open market transactions pursuant to this program during Q1 2026 were as detailed below. On April 28, 2026, our Board of Directors authorized a new 2026 Repurchase Program to repurchase up to $1.5 billion of our outstanding common stock. The 2026 Repurchase Program is in addition to the $1.5 billion previously authorized under the 2024 Repurchase Program.
Previous wording
During the quarterly period ended September 28, 2025, none of the Company’s directors or officers adopted, modified orterminated any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” in each case as such term is defined in Item 408 of Regulation S-K.
Current wording
Other than as disclosed above, during the quarterly period ended March 29, 2026, none of the Company’s directors or officers adopted, modified, or terminated any “Rule 10b5-1 trading arrangement” or any “non-Rule 10b5-1 trading arrangement,” in each case as such term is defined in Item 408 of Regulation S-K.